Monday, July 07, 2025 12:43:58 PM
People,People listen up !!!Over the 4th of July weekend some of our "Busy Body-Bad Guys" spent their time circulating 2 letters that were supposed to be responses from the UK-MHRA stating 2 things, 1) There is no application backlog and 2) The NWBO application has been returned to the company. The first response is accurate and the second response is a lie !!! I have managed public offerings ranging from natural resource, exploration partnerships to a publicly traded MLP on the NYSE. In my lifetime of experience dealing with securities rules and regulations, if I had ever received a letter from any regulatory agency addressing the condition or status of an application affecting the "Going Concern Value" of my company, my first and immediate responsibility to my shareholders would be to issue a PR clearly outlining and describing that MATERIAL EVENT!!!!
NWBO shareholders have been trained over the years to only rely on company PR's for validation of public statements fro any source. AF and the "Bad Guys" assume that NWBO shareholders are as stupid as he looked in the ASCO picture of him with his beer gut hanging to his knees' his dirty, untucked shirt and his Covid mask hanging off one ear!!! That is a big mistake on their part. Has there been a NWBO PR?? The answer is "NO" !! The company has repeatedly stated that the application process is ongoing and it will be until it's not and at that point , the company will receive notice of acceptance or rejection. As stated by the company on several occasions, "We are fully engaged in the application process" !!!
Cancer patients in need depend on responsible management actions to progress the approval of the company's breakthrough technology in immunotherapeutic treatments for large tumor cancers and THAT'S WHAT THEY ARE GETTING!!!
One point that should be noted is that the Bad Guys are using every tool in their box to prevent delivery of this life saving technology and the currency used to pay for their efforts are the lives of innocent cancer patients !!!!
BB
NWBO shareholders have been trained over the years to only rely on company PR's for validation of public statements fro any source. AF and the "Bad Guys" assume that NWBO shareholders are as stupid as he looked in the ASCO picture of him with his beer gut hanging to his knees' his dirty, untucked shirt and his Covid mask hanging off one ear!!! That is a big mistake on their part. Has there been a NWBO PR?? The answer is "NO" !! The company has repeatedly stated that the application process is ongoing and it will be until it's not and at that point , the company will receive notice of acceptance or rejection. As stated by the company on several occasions, "We are fully engaged in the application process" !!!
Cancer patients in need depend on responsible management actions to progress the approval of the company's breakthrough technology in immunotherapeutic treatments for large tumor cancers and THAT'S WHAT THEY ARE GETTING!!!
One point that should be noted is that the Bad Guys are using every tool in their box to prevent delivery of this life saving technology and the currency used to pay for their efforts are the lives of innocent cancer patients !!!!
BB
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
